Medicare Part B Oral Chemotherapy Demo Limited To Approved Indications
Executive Summary
Reimbursement for oral chemotherapy products under a Medicare Part B demonstration project will be limited to FDA-approved indications, the Centers for Medicare & Medicaid Services' proposed criteria say
You may also be interested in...
Medicare Part B Oral Chemotherapy Demo To Cover Tamoxifen, Thalidomide
Tamoxifen and thalidomide will be covered under the Medicare Part B oral drug replacement demonstration project, the Centers for Medicare & Medicaid Services said in announcing the start of the project June 24
Medicare Part B Oral Chemotherapy Demo To Cover Tamoxifen, Thalidomide
Tamoxifen and thalidomide will be covered under the Medicare Part B oral drug replacement demonstration project, the Centers for Medicare & Medicaid Services said in announcing the start of the project June 24
Medicare Part B Demo To Be Administered By Caremark, Trailblazer Health
Caremark/AdvancePCS and Trailblazer Health Enterprises will administer the Medicare Part B replacement drug demonstration project